Robin P. Kraak

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

Joanna J. Wykrzykowska, Robin P. Kraak, Sjoerd H. Hofma et al. · New England Journal of Medicine · 2017 · 435 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Robin P. Kraak, Mariëlla E.C.J. Hassell, Maik J. Grundeken et al. · EuroIntervention · 2015 · 131 citations · Full text

Medicine, Cardiology, Surgery +17

Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design

Pier Woudstra, Maik J. Grundeken, Robin P. Kraak et al. · American Heart Journal · 2013 · 42 citations

Medicine, Cardiology, Pharmacotherapy +17

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

R. Tijssen, Robin P. Kraak, Sjoerd H. Hofma et al. · EuroIntervention · 2018 · 31 citations · Full text

Medicine, Cardiology, Comparative Effectiveness Research +16

The IMPACT Study (Influence of Sensor-Equipped Microcatheters on Coronary Hemodynamics and the Accuracy of Physiological Indices of Functional Stenosis Severity)

Gilbert Wijntjens, Tim P. van de Hoef, Robin P. Kraak et al. · Circulation Cardiovascular Interventions · 2016 · 17 citations · Full text

Medicine, Cardiology, Surgery +17